Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) shares were down 1.3% on Tuesday . The stock traded as low as $4.77 and last traded at $4.90. Approximately 198,435 shares traded hands during mid-day trading, an increase of 93% from the average daily volume of 102,933 shares. The stock had previously closed at $4.97.
Ono Pharmaceutical Stock Performance
The company’s 50 day moving average price is $5.25 and its 200 day moving average price is $5.61.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
See Also
- Five stocks we like better than Ono Pharmaceutical
- Why Invest in 5G Stocks
- Garmin Navigates to New Highs Driven By Wearables Trend
- Best Stocks Under $5.00
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Calculate Options Profits
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
